The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...

Sanofi India Q3 Results Live : Sanofi India announced its Q3 results on November 7, 2024, revealing a significant decline in ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

Sanofi announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in Opella.

Janney Montgomery Scott LLC lessened its stake in Sanofi (NASDAQ:SNY – Free Report) by 0.3% in the third quarter, according ...

Sanofi (NASDAQ:SNY – Free Report) by 30.4% during the third quarter, according to the company in its most recent filing with ...

Brad Lightcap, COO, OpenAI "We believe AI can accelerate drug development, bringing new treatments to patients more quickly. This first product from our collaboration with Sanofi and Formation Bio is ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

Find out more about the collaboration between SandboxAQ and Sanofi, which aims to identify biomarkers using large ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Among these, Bristol Myers Squibb, Gilead Sciences and Sanofi stood out with robust growth ... benefited from regulatory wins ...